<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://bloodjournal.hematologylibrary.org">
<title>Blood RED CELLS</title>
<link>http://bloodjournal.hematologylibrary.org</link>
<description>Blood RSS feed -- recent RED CELLS articles</description>
<prism:eIssn>1528-0020</prism:eIssn>
<prism:publicationName>Blood</prism:publicationName>
<prism:issn>0006-4971</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/5195?rss=1" />
  <rdf:li rdf:resource="http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/5205?rss=1" />
  <rdf:li rdf:resource="http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/5215?rss=1" />
  <rdf:li rdf:resource="http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/5223?rss=1" />
  <rdf:li rdf:resource="http://bloodjournal.hematologylibrary.org/cgi/content/short/111/8/4375?rss=1" />
  <rdf:li rdf:resource="http://bloodjournal.hematologylibrary.org/cgi/content/short/111/7/3872?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://bloodjournal.hematologylibrary.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://bloodjournal.hematologylibrary.org/icons/banner/title.gif">
<title>Blood</title>
<url>http://bloodjournal.hematologylibrary.org/icons/banner/title.gif</url>
<link>http://bloodjournal.hematologylibrary.org</link>
</image>

<item rdf:about="http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/5195?rss=1">
<title><![CDATA[Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin]]></title>
<link>http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/5195?rss=1</link>
<description><![CDATA[
<p>Hemojuvelin (HJV) is a coreceptor for bone morphogenetic protein (BMP) signaling that regulates hepcidin expression and iron metabolism. However, the precise combinations of BMP ligands and receptors used by HJV remain unknown. HJV has also been demonstrated to bind to neogenin, but it is not known whether this interaction has a role in regulating hepcidin expression. In the present study, we show that BMP-2, BMP-4, and BMP-6 are endogenous ligands for HJV in hepatoma-derived cell lines, and that all 3 of these ligands are expressed in human liver. We demonstrate in vitro that HJV selectively uses the BMP type II receptors ActRIIA and BMPRII, but not ActRIIB, and HJV enhances utilization of ActRIIA by BMP-2 and BMP-4. Interestingly, ActRIIA is the predominant BMP type II receptor expressed in human liver. While HJV can use all 3 BMP type I receptors (ALK2, ALK3, and ALK6) in vitro, only ALK2 and ALK3 are detected in human liver. Finally, we show that HJV-induced BMP signaling and hepcidin expression are not altered by neogenin overexpression or by inhibition of endogenous neogenin expression. Thus, HJV-mediated BMP signaling and hepcidin regulation occur via a distinct subset of BMP ligands and BMP receptors, independently of neogenin.</p>
]]></description>
<dc:creator><![CDATA[Xia, Y., Babitt, J. L., Sidis, Y., Chung, R. T., Lin, H. Y.]]></dc:creator>
<dc:date>2008-05-08</dc:date>
<dc:subject><![CDATA[Red Cells]]></dc:subject>
<dc:identifier>info:doi/10.1182/blood-2007-09-111567</dc:identifier>
<dc:title><![CDATA[Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin]]></dc:title>
<dc:publisher>American Society of Hematology</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>111</prism:volume>
<prism:endingPage>5204</prism:endingPage>
<prism:publicationDate>2008-05-15</prism:publicationDate>
<prism:startingPage>5195</prism:startingPage>
<prism:section>RED CELLS</prism:section>
</item>

<item rdf:about="http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/5205?rss=1">
<title><![CDATA[Red blood cells induce hypoxic lung inflammation]]></title>
<link>http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/5205?rss=1</link>
<description><![CDATA[
<p>Hypoxia, which commonly associates with respiratory and cardiovascular diseases, provokes an acute inflammatory response. However, underlying mechanisms are not well understood. Here we report that red blood cells (RBCs) induce hypoxic inflammation by producing reactive oxygen species (ROS) that diffuse to endothelial cells of adjoining blood vessels. Real-time fluorescence imaging of rat and mouse lungs revealed that in the presence of RBC-containing vascular perfusion, hypoxia increased microvascular ROS, and cytosolic Ca<sup>2+</sup>, leading to P-selectin&ndash;dependent leukocyte recruitment. However, in the presence of RBC-free perfusion, all hypoxia-induced responses were completely inhibited. Because hemoglobin (Hb) autoxidation causes RBC superoxide formation that readily dismutates to H<SUB>2</SUB>O<SUB>2</SUB>, hypoxia-induced responses were lost when we inhibited Hb autoxidation with CO or nitrite, or when the H<SUB>2</SUB>O<SUB>2</SUB> inhibitor, catalase was added to the infusion to neutralize the RBC-derived ROS. By contrast, perfusion with RBCs from BERK-trait mice that are more susceptible to Hb autoxidation and to hypoxia-induced superoxide production enhanced the hypoxia-induced responses. We conclude that in hypoxia, increased Hb autoxidation augments superoxide production in RBCs. Consequently, RBCs release H<SUB>2</SUB>O<SUB>2</SUB> that diffuses to the lung microvascular endothelium, thereby initiating Ca<sup>2+</sup>-dependent leukocyte recruitment. These findings are the first evidence that RBCs contribute to hypoxia-induced inflammation.</p>
]]></description>
<dc:creator><![CDATA[Kiefmann, R., Rifkind, J. M., Nagababu, E., Bhattacharya, J.]]></dc:creator>
<dc:date>2008-05-08</dc:date>
<dc:subject><![CDATA[Red Cells]]></dc:subject>
<dc:identifier>info:doi/10.1182/blood-2007-09-113902</dc:identifier>
<dc:title><![CDATA[Red blood cells induce hypoxic lung inflammation]]></dc:title>
<dc:publisher>American Society of Hematology</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>111</prism:volume>
<prism:endingPage>5214</prism:endingPage>
<prism:publicationDate>2008-05-15</prism:publicationDate>
<prism:startingPage>5205</prism:startingPage>
<prism:section>RED CELLS</prism:section>
</item>

<item rdf:about="http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/5215?rss=1">
<title><![CDATA[Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24]]></title>
<link>http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/5215?rss=1</link>
<description><![CDATA[
<p>Fanconi anemia (FA) is a genetic disease characterized by congenital abnormalities, bone marrow failure, and cancer susceptibility. A total of 13 FA proteins are involved in regulating genome surveillance and chromosomal stability. The FA core complex, consisting of 8 FA proteins (A/B/C/E/F/G/L/M), is essential for the monoubiquitination of FANCD2 and FANCI. FANCM is a human ortholog of the archaeal DNA repair protein Hef, and it contains a DEAH helicase and a nuclease domain. Here, we examined the effect of FANCM expression on the integrity and localization of the FA core complex. FANCM was exclusively localized to chromatin fractions and underwent cell cycle&ndash;dependent phosphorylation and dephosphorylation. FANCM-depleted HeLa cells had an intact FA core complex but were defective in chromatin localization of the complex. Moreover, depletion of the FANCM binding partner, FAAP24, disrupted the chromatin association of FANCM and destabilized FANCM, leading to defective recruitment of the FA core complex to chromatin. Our results suggest that FANCM is an anchor required for recruitment of the FA core complex to chromatin, and that the FANCM/FAAP24 interaction is essential for this chromatin-loading activity. Dysregulated loading of the FA core complex accounts, at least in part, for the characteristic cellular and developmental abnormalities in FA.</p>
]]></description>
<dc:creator><![CDATA[Kim, J. M., Kee, Y., Gurtan, A., D'Andrea, A. D.]]></dc:creator>
<dc:date>2008-05-08</dc:date>
<dc:subject><![CDATA[Red Cells]]></dc:subject>
<dc:identifier>info:doi/10.1182/blood-2007-09-113092</dc:identifier>
<dc:title><![CDATA[Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24]]></dc:title>
<dc:publisher>American Society of Hematology</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>111</prism:volume>
<prism:endingPage>5222</prism:endingPage>
<prism:publicationDate>2008-05-15</prism:publicationDate>
<prism:startingPage>5215</prism:startingPage>
<prism:section>RED CELLS</prism:section>
</item>

<item rdf:about="http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/5223?rss=1">
<title><![CDATA[Repression via the GATA box is essential for tissue-specific erythropoietin gene expression]]></title>
<link>http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/5223?rss=1</link>
<description><![CDATA[
<p>In response to anemia, erythropoietin <I>(Epo)</I> gene transcription is markedly induced in the kidney and liver. To elucidate how <I>Epo</I> gene expression is regulated in vivo, we established transgenic mouse lines expressing green fluorescent protein (GFP) under the control of a 180-kb mouse <I>Epo</I> gene locus. GFP expression was induced by anemia or hypoxia specifically in peritubular interstitial cells of the kidney and hepatocytes surrounding the central vein. Surprisingly, renal Epo-producing cells had a neuronlike morphology and expressed neuronal marker genes. Furthermore, the regulatory mechanisms of <I>Epo</I> gene expression were explored using transgenes containing mutations in the GATA motif of the promoter region. A single nucleotide mutation in this motif resulted in constitutive ectopic expression of transgenic GFP in renal distal tubules, collecting ducts, and certain populations of epithelial cells in other tissues. Since both GATA-2 and GATA-3 bind to the GATA box in distal tubular cells, both factors are likely to repress constitutively ectopic <I>Epo</I> gene expression in these cells. Thus, GATA-based repression is essential for the inducible and cell type&ndash;specific expression of the <I>Epo</I> gene.</p>
]]></description>
<dc:creator><![CDATA[Obara, N., Suzuki, N., Kim, K., Nagasawa, T., Imagawa, S., Yamamoto, M.]]></dc:creator>
<dc:date>2008-05-08</dc:date>
<dc:subject><![CDATA[Red Cells, Gene Expression, Chemokines, Cytokines, and Interleukins]]></dc:subject>
<dc:identifier>info:doi/10.1182/blood-2007-10-115857</dc:identifier>
<dc:title><![CDATA[Repression via the GATA box is essential for tissue-specific erythropoietin gene expression]]></dc:title>
<dc:publisher>American Society of Hematology</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>111</prism:volume>
<prism:endingPage>5232</prism:endingPage>
<prism:publicationDate>2008-05-15</prism:publicationDate>
<prism:startingPage>5223</prism:startingPage>
<prism:section>RED CELLS</prism:section>
</item>

<item rdf:about="http://bloodjournal.hematologylibrary.org/cgi/content/short/111/8/4375?rss=1">
<title><![CDATA[Ablation of Gata1 in adult mice results in aplastic crisis, revealing its essential role in steady-state and stress erythropoiesis]]></title>
<link>http://bloodjournal.hematologylibrary.org/cgi/content/short/111/8/4375?rss=1</link>
<description><![CDATA[
<p>The transcription factor Gata1 is expressed in several hematopoietic lineages and plays essential roles in normal hematopoietic development during embryonic stages. The lethality of Gata1-<I>null</I> embryos has precluded determination of its role in adult erythropoiesis. Here we have examined the effects of Gata1 loss in adult erythropoiesis using conditional <I>Gata1</I> knockout mice expressing either interferon- or tamoxifen-inducible Cre recombinase (Mx-Cre and Tx-Cre, respectively). Mx-Cre&ndash;mediated <I>Gata1</I> recombination, although incomplete, resulted in maturation arrest of Gata1-<I>null</I> erythroid cells at the proerythroblast stage, thrombocytopenia, and excessive proliferation of megakaryocytes in the spleen. Tx-Cre&ndash;mediated <I>Gata1</I> recombination resulted in depletion of the erythroid compartment in bone marrow and spleen. Formation of the early and late erythroid progenitors in bone marrow was significantly reduced in the absence of Gata1. Furthermore, on treatment with a hemolytic agent, these mice failed to activate a stress erythropoietic response, despite the rising erythropoietin levels. These results indicate that, in addition to the requirement of Gata1 in adult megakaryopoiesis, Gata1 is necessary for steady-state erythropoiesis and for erythroid expansion in response to anemia. Thus, ablation of <I>Gata1</I> in adult mice results in a condition resembling aplastic crisis in human.</p>
]]></description>
<dc:creator><![CDATA[Gutierrez, L., Tsukamoto, S., Suzuki, M., Yamamoto-Mukai, H., Yamamoto, M., Philipsen, S., Ohneda, K.]]></dc:creator>
<dc:date>2008-04-08</dc:date>
<dc:subject><![CDATA[Hematopoiesis, Red Cells]]></dc:subject>
<dc:identifier>info:doi/10.1182/blood-2007-09-115121</dc:identifier>
<dc:title><![CDATA[Ablation of Gata1 in adult mice results in aplastic crisis, revealing its essential role in steady-state and stress erythropoiesis]]></dc:title>
<dc:publisher>American Society of Hematology</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>111</prism:volume>
<prism:endingPage>4385</prism:endingPage>
<prism:publicationDate>2008-04-15</prism:publicationDate>
<prism:startingPage>4375</prism:startingPage>
<prism:section>RED CELLS</prism:section>
</item>

<item rdf:about="http://bloodjournal.hematologylibrary.org/cgi/content/short/111/7/3872?rss=1">
<title><![CDATA[Genetic endothelial systems biology of sickle stroke risk]]></title>
<link>http://bloodjournal.hematologylibrary.org/cgi/content/short/111/7/3872?rss=1</link>
<description><![CDATA[
<p>Genetic differences in endothelial biology could underlie development of phenotypic heterogeneity among persons afflicted with vascular diseases. We obtained blood outgrowth endothelial cells from 20 subjects with sickle cell anemia (age, 4-19 years) shown to be either at-risk (n = 11) or not-at-risk (n = 9) for ischemic stroke because of, respectively, having or not having occlusive disease at the circle of Willis. Gene expression profiling identified no significant single gene differences between the 2 groups, as expected. However, analysis of Biological Systems Scores, using gene sets that were predetermined to survey each of 9 biologic systems, showed that only changes in inflammation signaling are characteristic of the at-risk subjects, as supported by multiple statistical approaches. Correspondingly, subsequent biologic testing showed significantly exaggerated RelA activation on the part of blood outgrowth endothelial cells from the at-risk subjects in response to stimulation with interleukin-1&beta;/tumor necrosis factor. We conclude that the pathobiology of circle of Willis disease in the child with sickle cell anemia predominantly involves inflammation biology, which could reflect differences in genetically determined endothelial biology that account for differing host responses to inflammation.</p>
]]></description>
<dc:creator><![CDATA[Chang Milbauer, L., Wei, P., Enenstein, J., Jiang, A., Hillery, C. A., Scott, J. P., Nelson, S. C., Bodempudi, V., Topper, J. N., Yang, R.-B., Hirsch, B., Pan, W., Hebbel, R. P.]]></dc:creator>
<dc:date>2008-03-24</dc:date>
<dc:subject><![CDATA[Hemostasis, Thrombosis, and Vascular Biology, Red Cells, Clinical Trials and Observations]]></dc:subject>
<dc:identifier>info:doi/10.1182/blood-2007-06-097188</dc:identifier>
<dc:title><![CDATA[Genetic endothelial systems biology of sickle stroke risk]]></dc:title>
<dc:publisher>American Society of Hematology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>111</prism:volume>
<prism:endingPage>3879</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>3872</prism:startingPage>
<prism:section>RED CELLS</prism:section>
</item>

</rdf:RDF>